Natural Alternatives International, Inc. (NAII)
Stock Price Chart
Key Info
| Market Cap | 45.01M |
| Revenue (ttm) | 114.04M |
| Net Income (ttm) | -3.64M |
| Shares Out | 6.79M |
| EPS (ttm) | -0.54 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Aug 11, 2020 |
| Last Price | $6.63 |
| Previous Close | $6.79 |
| Change ($) | -0.16 |
| Change (%) | -2.36% |
| Day's Open | 6.80 |
| Day's Range | 6.63 - 7.22 |
| Day's Volume | 13,241 |
| 52-Week Range | 4.75 - 11.14 |
More Stats
| Market Cap | 45.01M |
| Enterprise Value | 40.92M |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 6.79M |
| Float | 4.46M |
| EPS (basic) | -0.56 |
| EPS (diluted) | -0.54 |
| FCF / Share | -0.07 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 3,564 |
| Short Ratio | 0.35 |
| Short % of Float | 0.04% |
| Beta | 0.45 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 0.39 |
| PB Ratio | 0.64 |
| Revenue | 114.04M |
| Operating Income | -4.39M |
| Net Income | -3.64M |
| Free Cash Flow | -437,000 |
| Net Cash | 4.09M |
| Net Cash / Share | 0.60 |
| Gross Margin | 20.67% |
| Operating Margin | -3.85% |
| Profit Margin | -3.20% |
| FCF Margin | -0.38% |
| ROA | -1.14% |
| ROE | -4.92% |
| ROIC | n/a |
Analyst Summary
Analyst Consensus: n/a
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 138 | 132 | 122 | 114 | 79.51 | 73.94 | 62.80 | 72.82 | 55.88 | 65.55 |
| Revenue Growth | 4.42% | 8.6% | 6.78% | 43.63% | 7.53% | 17.75% | -13.77% | 30.31% | -14.75% | - |
| Gross Profit | 23.58 | 26.32 | 26.20 | 25.26 | 14.34 | 12.74 | 12.14 | 15.45 | 10.63 | 10.85 |
| Operating Income | 5.96 | 9.53 | 9.70 | 12.26 | 4.16 | 2.78 | 2.15 | 6.20 | 2.33 | 3.27 |
| Net Income | 6.54 | 5.05 | 7.24 | 9.55 | 3.35 | 1.99 | 1.57 | 4.16 | 5.09 | 4.13 |
| Shares Outstanding | 6.81 | 6.64 | 6.58 | 6.52 | 6.75 | 6.82 | 6.87 | 6.98 | 7.11 | 7.08 |
| Earnings Per Share | 0.92 | 0.73 | 1.09 | 1.44 | 0.49 | 0.29 | 0.23 | 0.59 | 0.71 | 0.58 |
| EPS Growth | 26.03% | -33.03% | -24.31% | 193.88% | 68.97% | 26.09% | -61.02% | -16.9% | 22.41% | - |
| Operating Cash Flow | 6.56 | 1.83 | 14.14 | 9.29 | 2.68 | 5.35 | 4.47 | 1.71 | 9.09 | 7.09 |
| Capital Expenditures | -5.31 | -4.05 | -5.33 | -7.44 | -1.62 | -2.47 | -1.59 | -2.28 | -1.67 | -2.52 |
| Free Cash Flow | 1.26 | -2.22 | 8.81 | 1.84 | 1.06 | 2.88 | 2.89 | -0.58 | 7.42 | 4.57 |
| Cash & Equivalents | 25.04 | 25.11 | 27.84 | 19.75 | 18.55 | 19.51 | 16.70 | 14.48 | 15.46 | 8.55 |
| Net Cash / Debt | 25.04 | 25.11 | 27.84 | 19.75 | 18.55 | 19.51 | 16.70 | 14.48 | 15.46 | 8.55 |
| Assets | 93.49 | 85.21 | 72.61 | 74.18 | 53.82 | 52.26 | 46.64 | 47.20 | 41.14 | 36.15 |
| Liabilities | 17.41 | 16.96 | 11.46 | 20.45 | 9.96 | 9.82 | 6.30 | 7.33 | 5.67 | 5.54 |
| Book Value | 76.08 | 68.25 | 61.15 | 53.73 | 43.86 | 42.44 | 40.34 | 39.87 | 35.48 | 30.61 |
Company Profile
Company Details
| Full Name | Natural Alternatives International, Inc. |
| Country | United States |
| Employees | 271 |
| CEO | Mark A. LeDoux |
Stock Information
| Ticker Symbol | NAII |
| Stock Exchange | NASDAQ |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Unique Identifier | NASDAQ: NAII |
| IPO Date | March 13, 1987 |
Description
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, the company sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. It manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. The company's private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.